Novel & Dual Payloads: Assessing Linker Conjugation Technologies That Encourage Flexibility in Payloads
- Evaluating the right ratios, the advantages of releasing drugs in specific ratios, and which combination of drugs make sense when considering dual payloads
- Discussing how novel payloads hold promise to overcome drug resistance
- Advancing cytoxic or immune-stimulating payloads with novel MoAs